On May 18, John Theurer Cancer Center at HakensackUMC, one of the nation's top 50 cancer centers, will host the 8th Annual Neuro-Oncology Symposium. This year's program, titled New Horizons in Neuro-Oncology- Innovations in the Treatment of Brain Tumors, will bring leading experts to discuss the most important advancements and innovations for the treatment of patients with brain tumors. The symposium will be held on Friday, May 18 from 8:00am to 1:00pm.
"New research and innovations are constantly changing the way we diagnosis, manage, and treat neuro-oncology patients," George Kaptain, M.D., Co-Chief, Brain & Spine Institute, John Theurer Cancer Center "We are excited to bring in leading experts to our center to better understand how we can apply these latest findings to our clinics."
Featured speakers and their presentations include:
"The neuro-oncology symposium is a great opportunity for tri-state area healthcare professionals to learn about the latest brain tumor advancements from leaders in our field," said Samuel Goldlust, M.D., Co-Chief, Brain & Spine Institute, John Theurer Cancer Center. "Not only is it a very exciting time for progress in neuro-oncology, but also for our cancer center. With the recent opening of our Gamma Knife radiosurgery center and our robust clinical trials program we have helped to bring cutting-edge care for brain tumor patients to Northern New Jersey."
"Now in our eighth year, we look forward to hosting this program at our new, state-of-the-art cancer building," said Mark S. Pascal, M.D., Chief of Nero-Oncology, John Theurer Cancer Center. "Our comprehensive cancer facility brings our 14 divisions together under one roof, and encourages collaboration and a multidisciplinary approach among practicing physicians and staff."
The conference is located at John Theurer Cancer Center, 92 Second Street, Hackensack, NJ. This conference is complimentary, however registration is required. Please contact Maryann V. Lederhilger at 551-996-1162 or MLederhilger@HackensackUMC.org.
This conference is primarily for neuro and medical oncologists, neurologists, neurosurgeons, radiation therapists, neuro-radiologists and primary care physicians as well as other healthcare professionals involved in the treatment of brain and spinal tumor patients. HackensackUMC designates this education activity for a maximum of 4.0 AMA PRA Category 1 Credits.
"This symposium is part of John Theurer Cancer Center's commitment to help physicians and other healthcare professionals remain on the forefront of cancer care through continuing medical education programs," said Andrew L Pecora, M.D., F.A.C.P., C.P.E, Chief Innovations Officer, Professor, and Vice President of Cancer Services.
|Contact: Amy Leahing|
John Theurer Cancer Center